Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia

Leuk Lymphoma. 2025 Jan 16:1-5. doi: 10.1080/10428194.2024.2443017. Online ahead of print.

¹ Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN, USA.
² Department of Pharmacy Services, Mayo Clinic, Rochester, MN, USA.
³ Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.

No abstract available

Keywords: ALL; FLAG-Ida; ambiguous lineage; relapsed/refractory; venetoclax.